Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised

By admin
Estimated read time 1 min read
March 30, 2025
0 comments

Post Content

About The Author

admin

http://digitalgroundmedia.com

More From Author

David Zaslav thinks HBO Max is ‘way underpriced’

A California bill that would regulate AI companion chatbots is close to becoming law

Perplexity reportedly raised $200M at $20B valuation

Leave a Reply Cancel reply

Affiliate Disclosure: This site may contain affiliate links to products and services. We may receive a commission for purchases made through these links at no extra cost to you. As an Amazon Associate, we earn from qualifying purchases. Your support helps keep this site running.

For information on how we handle user data and your consumer privacy rights, please refer to our Privacy Policy. This site is operated in compliance with applicable U.S. and California consumer protection laws.